Loading…
TRPM4 is overexpressed in breast cancer associated with estrogen response and epithelial-mesenchymal transition gene sets
Ion channels form an important class of drug targets in malignancies. Transient receptor potential cation channel subfamily M member 4 (TRPM4) plays oncological roles in various solid tumors. Herein, we examined TRPM4 protein expression profile by immunohistochemistry (IHC) in breast cancer cases co...
Saved in:
Published in: | PloS one 2020-06, Vol.15 (6), p.e0233884-e0233884 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c669t-c2e266ccf0a297d7250ebfc310b4492aebf4521a929cc0dee60479f22fc01fe13 |
---|---|
cites | cdi_FETCH-LOGICAL-c669t-c2e266ccf0a297d7250ebfc310b4492aebf4521a929cc0dee60479f22fc01fe13 |
container_end_page | e0233884 |
container_issue | 6 |
container_start_page | e0233884 |
container_title | PloS one |
container_volume | 15 |
creator | Wong, Kah Keng Hussain, Faezahtul Arbaeyah |
description | Ion channels form an important class of drug targets in malignancies. Transient receptor potential cation channel subfamily M member 4 (TRPM4) plays oncological roles in various solid tumors. Herein, we examined TRPM4 protein expression profile by immunohistochemistry (IHC) in breast cancer cases compared with normal breast ducts, its association with clinico-demographical parameters, and its potential function in breast cancers by Gene Set Enrichment Analysis (GSEA). Data-mining demonstrated that TRPM4 transcript levels were significantly higher in The Cancer Genome Atlas series of breast cancer cases (n = 1,085) compared with normal breast tissues (n = 112) (p = 1.03 x 10.sup.-11). Our IHC findings in tissue microarrays showed that TRPM4 protein was overexpressed in breast cancers (n = 83/99 TRPM4.sup.+ ; 83.8%) compared with normal breast ducts (n = 5/10 TRPM4.sup.+ ; 50%) (p = 0.022). Higher TRPM4 expression (median frequency cut-off) was significantly associated with higher lymph node status (N1-N2 vs N0; p = 0.024) and higher stage (IIb-IIIb vs I-IIa; p = 0.005). GSEA evaluation in three independent gene expression profiling (GEP) datasets of breast cancer cases (GSE54002, n = 417; GSE20685, n = 327; GSE23720, n = 197) demonstrated significant association of TRPM4 transcript expression with estrogen response and epithelial-mesenchymal transition (EMT) gene sets (p |
doi_str_mv | 10.1371/journal.pone.0233884 |
format | article |
fullrecord | <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_2408808831</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A625540142</galeid><doaj_id>oai_doaj_org_article_a1b2ae0c388b4b0e9082ee03e69d2427</doaj_id><sourcerecordid>A625540142</sourcerecordid><originalsourceid>FETCH-LOGICAL-c669t-c2e266ccf0a297d7250ebfc310b4492aebf4521a929cc0dee60479f22fc01fe13</originalsourceid><addsrcrecordid>eNqNk11rFDEUhgdRbK3-A8GAIHqxa77m60YoxY-FSqVWb0Mmc2Y3y2yyzcnU7r832x2lI72QGZhMznPek_OSk2UvGZ0zUbL3az8Ep_v51juYUy5EVclH2TGrBZ8VnIrH99ZH2TPENaW5qIriaXYkuKxkxflxtru6_PZVEovE30CA220ARGiJdaQJoDESo52BQDSiN1bHFPtl44oAxuCX4EhKSEdAINq1BLYpBr3V_WwDCM6sdhvdkxi0QxutdySlAEGI-Dx70uke4cX4Pcl-fPp4dfZldn7xeXF2ej4zRVHHmeHAi8KYjmpel23JcwpNZwSjjZQ11-lH5pzpmtfG0BagoLKsO847Q1kHTJxkrw66296jGl1DxSWtqvSKPbE4EK3Xa7UNdqPDTnlt1d2GD0ulQ7SmB6VZk0pSk8xuZEOhphUHoAKKuuWSl0nrw1htaDbQGnCp934iOo04u1JLf6PK1CWv8yTwdhQI_npILquNRQN9rx344e7cNUvNFjShr_9BH-5upJY6NWBd51NdsxdVpwXPc0mZ5ImaP0Clp4WNNemKdTbtTxLeTRISE-E2LvWAqBbfL_-fvfg5Zd_cY1eg-7hC3w_7y4NTUB5AEzxigO6vyYyq_YT8cUPtJ0SNEyJ-A5m7A3g</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2408808831</pqid></control><display><type>article</type><title>TRPM4 is overexpressed in breast cancer associated with estrogen response and epithelial-mesenchymal transition gene sets</title><source>PubMed (Medline)</source><source>Publicly Available Content Database</source><creator>Wong, Kah Keng ; Hussain, Faezahtul Arbaeyah</creator><contributor>Vranic, Semir</contributor><creatorcontrib>Wong, Kah Keng ; Hussain, Faezahtul Arbaeyah ; Vranic, Semir</creatorcontrib><description>Ion channels form an important class of drug targets in malignancies. Transient receptor potential cation channel subfamily M member 4 (TRPM4) plays oncological roles in various solid tumors. Herein, we examined TRPM4 protein expression profile by immunohistochemistry (IHC) in breast cancer cases compared with normal breast ducts, its association with clinico-demographical parameters, and its potential function in breast cancers by Gene Set Enrichment Analysis (GSEA). Data-mining demonstrated that TRPM4 transcript levels were significantly higher in The Cancer Genome Atlas series of breast cancer cases (n = 1,085) compared with normal breast tissues (n = 112) (p = 1.03 x 10.sup.-11). Our IHC findings in tissue microarrays showed that TRPM4 protein was overexpressed in breast cancers (n = 83/99 TRPM4.sup.+ ; 83.8%) compared with normal breast ducts (n = 5/10 TRPM4.sup.+ ; 50%) (p = 0.022). Higher TRPM4 expression (median frequency cut-off) was significantly associated with higher lymph node status (N1-N2 vs N0; p = 0.024) and higher stage (IIb-IIIb vs I-IIa; p = 0.005). GSEA evaluation in three independent gene expression profiling (GEP) datasets of breast cancer cases (GSE54002, n = 417; GSE20685, n = 327; GSE23720, n = 197) demonstrated significant association of TRPM4 transcript expression with estrogen response and epithelial-mesenchymal transition (EMT) gene sets (p<0.01 and false discovery rate<0.05). These gene sets were not enriched in GEP datasets of normal breast epithelium cases (GSE10797, n = 5; GSE9574, n = 15; GSE20437, n = 18). In conclusion, TRPM4 protein expression is upregulated in breast cancers associated with worse clinico-demographical parameters, and TRPM4 potentially regulates estrogen receptor signaling and EMT progression in breast cancer.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0233884</identifier><identifier>PMID: 32484822</identifier><language>eng</language><publisher>San Francisco: Public Library of Science</publisher><subject>Antibodies ; Appendicitis ; Biology and Life Sciences ; Breast cancer ; Cancer genetics ; Cancer treatment ; Cell transformation ; Colorectal cancer ; Criminal investigation ; Data mining ; Datasets ; Development and progression ; DNA microarrays ; EDTA ; Epithelium ; Estrogen receptors ; Estrogens ; Ethanol ; Females ; Gene expression ; Gene set enrichment analysis ; Genes ; Genetic aspects ; Genomes ; Genomics ; Health aspects ; Immunohistochemistry ; Ion channels ; Lymph nodes ; Lymphatic system ; Medicine and Health Sciences ; Mesenchyme ; Parameters ; Pathology ; Patients ; Phenols (Class of compounds) ; Prostate cancer ; Proteins ; Receptors ; Research and Analysis Methods ; Solid tumors ; Stem cells ; Therapeutic targets ; Transcription ; Transient receptor potential proteins ; Tumors ; Values</subject><ispartof>PloS one, 2020-06, Vol.15 (6), p.e0233884-e0233884</ispartof><rights>COPYRIGHT 2020 Public Library of Science</rights><rights>2020 Wong, Hussain. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2020 Wong, Hussain 2020 Wong, Hussain</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c669t-c2e266ccf0a297d7250ebfc310b4492aebf4521a929cc0dee60479f22fc01fe13</citedby><cites>FETCH-LOGICAL-c669t-c2e266ccf0a297d7250ebfc310b4492aebf4521a929cc0dee60479f22fc01fe13</cites><orcidid>0000-0001-7359-6202</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2408808831/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2408808831?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids></links><search><contributor>Vranic, Semir</contributor><creatorcontrib>Wong, Kah Keng</creatorcontrib><creatorcontrib>Hussain, Faezahtul Arbaeyah</creatorcontrib><title>TRPM4 is overexpressed in breast cancer associated with estrogen response and epithelial-mesenchymal transition gene sets</title><title>PloS one</title><description>Ion channels form an important class of drug targets in malignancies. Transient receptor potential cation channel subfamily M member 4 (TRPM4) plays oncological roles in various solid tumors. Herein, we examined TRPM4 protein expression profile by immunohistochemistry (IHC) in breast cancer cases compared with normal breast ducts, its association with clinico-demographical parameters, and its potential function in breast cancers by Gene Set Enrichment Analysis (GSEA). Data-mining demonstrated that TRPM4 transcript levels were significantly higher in The Cancer Genome Atlas series of breast cancer cases (n = 1,085) compared with normal breast tissues (n = 112) (p = 1.03 x 10.sup.-11). Our IHC findings in tissue microarrays showed that TRPM4 protein was overexpressed in breast cancers (n = 83/99 TRPM4.sup.+ ; 83.8%) compared with normal breast ducts (n = 5/10 TRPM4.sup.+ ; 50%) (p = 0.022). Higher TRPM4 expression (median frequency cut-off) was significantly associated with higher lymph node status (N1-N2 vs N0; p = 0.024) and higher stage (IIb-IIIb vs I-IIa; p = 0.005). GSEA evaluation in three independent gene expression profiling (GEP) datasets of breast cancer cases (GSE54002, n = 417; GSE20685, n = 327; GSE23720, n = 197) demonstrated significant association of TRPM4 transcript expression with estrogen response and epithelial-mesenchymal transition (EMT) gene sets (p<0.01 and false discovery rate<0.05). These gene sets were not enriched in GEP datasets of normal breast epithelium cases (GSE10797, n = 5; GSE9574, n = 15; GSE20437, n = 18). In conclusion, TRPM4 protein expression is upregulated in breast cancers associated with worse clinico-demographical parameters, and TRPM4 potentially regulates estrogen receptor signaling and EMT progression in breast cancer.</description><subject>Antibodies</subject><subject>Appendicitis</subject><subject>Biology and Life Sciences</subject><subject>Breast cancer</subject><subject>Cancer genetics</subject><subject>Cancer treatment</subject><subject>Cell transformation</subject><subject>Colorectal cancer</subject><subject>Criminal investigation</subject><subject>Data mining</subject><subject>Datasets</subject><subject>Development and progression</subject><subject>DNA microarrays</subject><subject>EDTA</subject><subject>Epithelium</subject><subject>Estrogen receptors</subject><subject>Estrogens</subject><subject>Ethanol</subject><subject>Females</subject><subject>Gene expression</subject><subject>Gene set enrichment analysis</subject><subject>Genes</subject><subject>Genetic aspects</subject><subject>Genomes</subject><subject>Genomics</subject><subject>Health aspects</subject><subject>Immunohistochemistry</subject><subject>Ion channels</subject><subject>Lymph nodes</subject><subject>Lymphatic system</subject><subject>Medicine and Health Sciences</subject><subject>Mesenchyme</subject><subject>Parameters</subject><subject>Pathology</subject><subject>Patients</subject><subject>Phenols (Class of compounds)</subject><subject>Prostate cancer</subject><subject>Proteins</subject><subject>Receptors</subject><subject>Research and Analysis Methods</subject><subject>Solid tumors</subject><subject>Stem cells</subject><subject>Therapeutic targets</subject><subject>Transcription</subject><subject>Transient receptor potential proteins</subject><subject>Tumors</subject><subject>Values</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNqNk11rFDEUhgdRbK3-A8GAIHqxa77m60YoxY-FSqVWb0Mmc2Y3y2yyzcnU7r832x2lI72QGZhMznPek_OSk2UvGZ0zUbL3az8Ep_v51juYUy5EVclH2TGrBZ8VnIrH99ZH2TPENaW5qIriaXYkuKxkxflxtru6_PZVEovE30CA220ARGiJdaQJoDESo52BQDSiN1bHFPtl44oAxuCX4EhKSEdAINq1BLYpBr3V_WwDCM6sdhvdkxi0QxutdySlAEGI-Dx70uke4cX4Pcl-fPp4dfZldn7xeXF2ej4zRVHHmeHAi8KYjmpel23JcwpNZwSjjZQ11-lH5pzpmtfG0BagoLKsO847Q1kHTJxkrw66296jGl1DxSWtqvSKPbE4EK3Xa7UNdqPDTnlt1d2GD0ulQ7SmB6VZk0pSk8xuZEOhphUHoAKKuuWSl0nrw1htaDbQGnCp934iOo04u1JLf6PK1CWv8yTwdhQI_npILquNRQN9rx344e7cNUvNFjShr_9BH-5upJY6NWBd51NdsxdVpwXPc0mZ5ImaP0Clp4WNNemKdTbtTxLeTRISE-E2LvWAqBbfL_-fvfg5Zd_cY1eg-7hC3w_7y4NTUB5AEzxigO6vyYyq_YT8cUPtJ0SNEyJ-A5m7A3g</recordid><startdate>20200602</startdate><enddate>20200602</enddate><creator>Wong, Kah Keng</creator><creator>Hussain, Faezahtul Arbaeyah</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-7359-6202</orcidid></search><sort><creationdate>20200602</creationdate><title>TRPM4 is overexpressed in breast cancer associated with estrogen response and epithelial-mesenchymal transition gene sets</title><author>Wong, Kah Keng ; Hussain, Faezahtul Arbaeyah</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c669t-c2e266ccf0a297d7250ebfc310b4492aebf4521a929cc0dee60479f22fc01fe13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Antibodies</topic><topic>Appendicitis</topic><topic>Biology and Life Sciences</topic><topic>Breast cancer</topic><topic>Cancer genetics</topic><topic>Cancer treatment</topic><topic>Cell transformation</topic><topic>Colorectal cancer</topic><topic>Criminal investigation</topic><topic>Data mining</topic><topic>Datasets</topic><topic>Development and progression</topic><topic>DNA microarrays</topic><topic>EDTA</topic><topic>Epithelium</topic><topic>Estrogen receptors</topic><topic>Estrogens</topic><topic>Ethanol</topic><topic>Females</topic><topic>Gene expression</topic><topic>Gene set enrichment analysis</topic><topic>Genes</topic><topic>Genetic aspects</topic><topic>Genomes</topic><topic>Genomics</topic><topic>Health aspects</topic><topic>Immunohistochemistry</topic><topic>Ion channels</topic><topic>Lymph nodes</topic><topic>Lymphatic system</topic><topic>Medicine and Health Sciences</topic><topic>Mesenchyme</topic><topic>Parameters</topic><topic>Pathology</topic><topic>Patients</topic><topic>Phenols (Class of compounds)</topic><topic>Prostate cancer</topic><topic>Proteins</topic><topic>Receptors</topic><topic>Research and Analysis Methods</topic><topic>Solid tumors</topic><topic>Stem cells</topic><topic>Therapeutic targets</topic><topic>Transcription</topic><topic>Transient receptor potential proteins</topic><topic>Tumors</topic><topic>Values</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wong, Kah Keng</creatorcontrib><creatorcontrib>Hussain, Faezahtul Arbaeyah</creatorcontrib><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Science (Gale in Context)</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological & Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Advanced Technologies & Aerospace Database (1962 - current)</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>https://resources.nclive.org/materials</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Meteorological & Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>Biological Sciences</collection><collection>Agriculture Science Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>ProQuest Biological Science Journals</collection><collection>Engineering Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest advanced technologies & aerospace journals</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials science collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wong, Kah Keng</au><au>Hussain, Faezahtul Arbaeyah</au><au>Vranic, Semir</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>TRPM4 is overexpressed in breast cancer associated with estrogen response and epithelial-mesenchymal transition gene sets</atitle><jtitle>PloS one</jtitle><date>2020-06-02</date><risdate>2020</risdate><volume>15</volume><issue>6</issue><spage>e0233884</spage><epage>e0233884</epage><pages>e0233884-e0233884</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Ion channels form an important class of drug targets in malignancies. Transient receptor potential cation channel subfamily M member 4 (TRPM4) plays oncological roles in various solid tumors. Herein, we examined TRPM4 protein expression profile by immunohistochemistry (IHC) in breast cancer cases compared with normal breast ducts, its association with clinico-demographical parameters, and its potential function in breast cancers by Gene Set Enrichment Analysis (GSEA). Data-mining demonstrated that TRPM4 transcript levels were significantly higher in The Cancer Genome Atlas series of breast cancer cases (n = 1,085) compared with normal breast tissues (n = 112) (p = 1.03 x 10.sup.-11). Our IHC findings in tissue microarrays showed that TRPM4 protein was overexpressed in breast cancers (n = 83/99 TRPM4.sup.+ ; 83.8%) compared with normal breast ducts (n = 5/10 TRPM4.sup.+ ; 50%) (p = 0.022). Higher TRPM4 expression (median frequency cut-off) was significantly associated with higher lymph node status (N1-N2 vs N0; p = 0.024) and higher stage (IIb-IIIb vs I-IIa; p = 0.005). GSEA evaluation in three independent gene expression profiling (GEP) datasets of breast cancer cases (GSE54002, n = 417; GSE20685, n = 327; GSE23720, n = 197) demonstrated significant association of TRPM4 transcript expression with estrogen response and epithelial-mesenchymal transition (EMT) gene sets (p<0.01 and false discovery rate<0.05). These gene sets were not enriched in GEP datasets of normal breast epithelium cases (GSE10797, n = 5; GSE9574, n = 15; GSE20437, n = 18). In conclusion, TRPM4 protein expression is upregulated in breast cancers associated with worse clinico-demographical parameters, and TRPM4 potentially regulates estrogen receptor signaling and EMT progression in breast cancer.</abstract><cop>San Francisco</cop><pub>Public Library of Science</pub><pmid>32484822</pmid><doi>10.1371/journal.pone.0233884</doi><tpages>e0233884</tpages><orcidid>https://orcid.org/0000-0001-7359-6202</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1932-6203 |
ispartof | PloS one, 2020-06, Vol.15 (6), p.e0233884-e0233884 |
issn | 1932-6203 1932-6203 |
language | eng |
recordid | cdi_plos_journals_2408808831 |
source | PubMed (Medline); Publicly Available Content Database |
subjects | Antibodies Appendicitis Biology and Life Sciences Breast cancer Cancer genetics Cancer treatment Cell transformation Colorectal cancer Criminal investigation Data mining Datasets Development and progression DNA microarrays EDTA Epithelium Estrogen receptors Estrogens Ethanol Females Gene expression Gene set enrichment analysis Genes Genetic aspects Genomes Genomics Health aspects Immunohistochemistry Ion channels Lymph nodes Lymphatic system Medicine and Health Sciences Mesenchyme Parameters Pathology Patients Phenols (Class of compounds) Prostate cancer Proteins Receptors Research and Analysis Methods Solid tumors Stem cells Therapeutic targets Transcription Transient receptor potential proteins Tumors Values |
title | TRPM4 is overexpressed in breast cancer associated with estrogen response and epithelial-mesenchymal transition gene sets |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T12%3A08%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=TRPM4%20is%20overexpressed%20in%20breast%20cancer%20associated%20with%20estrogen%20response%20and%20epithelial-mesenchymal%20transition%20gene%20sets&rft.jtitle=PloS%20one&rft.au=Wong,%20Kah%20Keng&rft.date=2020-06-02&rft.volume=15&rft.issue=6&rft.spage=e0233884&rft.epage=e0233884&rft.pages=e0233884-e0233884&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0233884&rft_dat=%3Cgale_plos_%3EA625540142%3C/gale_plos_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c669t-c2e266ccf0a297d7250ebfc310b4492aebf4521a929cc0dee60479f22fc01fe13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2408808831&rft_id=info:pmid/32484822&rft_galeid=A625540142&rfr_iscdi=true |